AEGON'S UK Smaller Companies fund is underweight the ‘unpredictable' biotech sector, having no exposure compared to nearly 5pc for the benchmark.
Elaine Morgan, who has run the £11m fund since its launch in June this year, said she was not overly keen on the sector and believed it was a difficult area to second-guess. “We are cautious on pharmaceuticals...
Duo start roles on 1 October
Where true value lies
Economy to thrive despite global risks
Behaviours, animals or something else?